Cognitive impairment in major depressive disorder
نویسندگان
چکیده
منابع مشابه
Major depressive disorder and cognitive impairment.
A 39-year-old accountant and married mother of 2 children has received pharmacotherapy and mindfulnessbased psychotherapy during the last 6 months to mitigate depressive symptoms as part of recurrent major depressive disorder (MDD), which began during her college years. Her PHQ-9 score is 4. She has reported inability to organize her thoughts, “fuzzy thinking” and poor memory. She has also expr...
متن کاملCognitive impairment in euthymic major depressive disorder: a meta-analysis.
BACKGROUND There is evidence to suggest that cognitive deficits might persist beyond the acute stages of illness in major depressive disorder (MDD). However, the findings are somewhat inconsistent across the individual studies conducted to date. Our aim was to conduct a systematic review and meta-analysis of existing studies that have examined cognition in euthymic MDD patients. METHOD Follow...
متن کاملEfficacy of Pharmacotherapy and Cognitive Therapy, Alone and in Combination in Major Depressive Disorder
Introduction & Objective: Patients with Major depressive are difficult to treat, and the relative efficacy of medications and cognitive therapy in the treatment of depression is still a matter of deabath. The purpose of this study was to compare the efficacies of antidepressant medication, cognitive therapy and combination of cognitive therapy and antidepressant medication. Materials & Met...
متن کاملNeurocognitive impairment in drug-free patients with major depressive disorder.
BACKGROUND Although neurocognitive impairment has been widely reported in major depressive disorder (MDD), confounding factors, such as the effects of psychotropic medication, have rarely been controlled for. AIMS To examine neurocognitive function in medication-free patients with MDD and healthy controls. METHOD Forty-four patients meeting DSM-IV criteria for MDD, all psychotropic-medicati...
متن کاملCognitive impairment and major depressive disorder in HIV infection and cerebrospinal fluid biomarkers.
Cognitive impairment and major depressive disorder (MDD) are common HIV-1 central nervous system (CNS) complications. Their frequencies in AIDS patients are 36% and 45%, respectively. The diagnoses of HIV cognitive impairment are made by clinical criteria, no single laboratory test or biomarker establishes the diagnosis. Factors of indirect neuronal injury related with the pathophysiology of th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: CNS Spectrums
سال: 2018
ISSN: 1092-8529,2165-6509
DOI: 10.1017/s1092852918001207